Breaking News, Collaborations & Alliances

WuXi AppTec, Qiagen Enter Biomarker Pact

WuXi AppTec has entered into a partnership with Qiagen to provide an integrated solution for molecular biomarker development, validation and personalized healthcare targets to their respective clients.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi AppTec has entered into a partnership with Qiagen to provide an integrated solution for molecular biomarker development, validation and personalized healthcare targets to their respective clients. Qiagen will provide instrumentation, training, and consumables and WuXi will provide lab services at its Shanghai campus. WuXi will also work with Qiagen to help develop biomarkers, assay panels, personalized healthcare diagnostics, and other products that Qiagen intends to bring to market. WuX...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters